|
Renamed Genes |
|
Previous Name | Previous Description | Current Name | Current Description |
|
AML1 | Acute Myeloid Leukemia 1 | RUNX1 | Runt Related Transcription Factor 1 |
|
Ang-1 | Angiopoietin-1 | ANGPT1 | Angiopoietin 1 |
|
BRN3A | Brain-3A | POU4F1 | POU Class 4 Homeobox 1 |
|
CD11c | CD11c Antigen | ITGAX | Integrin Subunit Alpha X |
|
CD133 | CD133 Antigen | PROM1 | Prominin 1 |
|
ELA2 | Elastase-2 | ELANE | Elastase, Neutrophil Expressed |
|
ETO | Protein ETO | RUNX1T1 | RUNX1 Translocation Partner 1 |
|
EVI1 | Ecotropic Viral Integration Site 1 | MECOM | MDS1 And EVI1 Complex Locus |
|
FLJ14054 | Homo sapiens cDNA FLJ14054 fis, clone HEMBB1000240 | NPR3 | Natriuretic Peptide Receptor 3 |
|
IL8 | Interleukin-8 | CXCL8 | C-X-C Motif Chemokine Ligand 8 |
|
MADH1 | Mothers Against Decapentaplegic Homolog 1 | SMAD1 | SMAD Family Member 1 |
|
MDR1 | Multidrug Resistance Protein 1 | ABCB1 | ATP Binding Cassette Subfamily B Member 1 |
|
MEL1 | MDS1/EVI1-Like Gene 1 | PRDM16 | PR/SET Domain 16 |
|
MLL | Mixed Lineage Leukemia | KMT2A | Lysine Methyltransferase 2A |
|
MLLT2 | Myeloid/Lymphoid Or Mixed-Lineage Leukemia (Trithorax (Drosophila) Homolog); Translocated To, 2 | AFF1 | AF4/FMR2 Family Member 1 |
|
MLLT4 | Myeloid/Lymphoid Or Mixed-Lineage Leukemia Translocated To, 4 | AFDN | Afadin, Adherens Junction Formation Factor |
|
NICAL | NEDD9-Interacting Protein With Calponin Homology And LIM Domains | MICAL1 | Microtubule Associated Monooxygenase, Calponin And LIM Domain Containing 1 |
|
OPN | Osteopontin | SPP1 | Secreted Phosphoprotein 1 |
|
PTRF | Polymerase I And Transcript Release Factor | CAVIN1 | Caveolae Associated Protein 1 |
|
PU.1 | Hematopoietic Transcription Factor PU.1 | SPI1 | Spi-1 Proto-Oncogene |
|
Abbreviations |
|
AML | acute myeloid leukemia |
|
ALL | acute lymphoblastic leukemia |
|
APL | acute promyelocytic leukemia |
|
BM | bone marrow |
|
CBF | core binding factor |
|
circRNAs | circular RNAs |
|
CLL | chronic lymphocytic leukemia |
|
CML | chronic myeloid leukemia |
|
CN-AML | cytogenetically normal AML |
|
CR | complete remission |
|
DEGs | differentially expressed genes |
|
DFS | disease-free survival |
|
FLT3-ITD | FLT3-internal tandem duplication |
|
FAB | French-American-British (classification system) |
|
GEP | gene expression profiling |
|
HH | Hedgehog |
|
HSCs | hematopoietic stem cells |
|
HSPCs | hematopoietic stem-progenitor cells |
|
lncRNAs | long noncoding RNAs |
|
LSCs | leukemic stem cells |
|
MDS | myelodysplastic syndromes |
|
MRD | minimal residual disease |
|
MSC | mesenchymal stem cells |
|
NGS | next generation sequencing |
|
NK-AML | normal karyotype AML |
|
NPMc+ | NPM-cytoplasmic positive |
|
OS | overall survival |
|
PB | peripheral blood |
|
PBMCs | peripheral blood mononuclear cells |
|
SAGE | serial analysis of gene expression |
|
snoRNAs | small nucleolar RNAs |
|
TCGA | the Cancer Genome Atlas |
|
TEs | transposable elements |
|
WBC | white blood cell |
|
WHO | World Health Organization |
|